DUBLIN--(BUSINESS WIRE)--The "Chitosan Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Grade; Application; Source" report has been added to ResearchAndMarkets.com's offering.
The global chitosan market was valued at US$ 1,764.3 million in 2018 and is projected to reach US$ 4,698.7 million by 2027; it is expected to grow at a CAGR of 11.5% from 2019 to 2027.
Chitosan is a natural fibrous material derived from chitin. Chitin is a substance that is produced in the outer shell of shellfish such as lobsters, crabs, and shrimps. Shrimps are considered to be a major source of chitosan as they contain about 25% to 40% of chitin content. Besides shell fish and crustaceans, certain varieties of fungi have also been known to produce low amounts of chitin in their cell walls. However, the lack of an optimal procedure for extraction of chitin on a commercial scale from fungi makes it a less used source for obtaining chitosan.
Chitosan is a rich fiber source and is increasingly incorporated into dietary supplements for promoting weight loss. It is a fibrous material which blocks the absorption of cholesterol and dietary fats and hence is used in medicines to cure diseases such as high cholesterol, obesity, and crohn's disease. Chitosan is also directly applied on the gums to alleviate inflammation of the gums.
Geographically, the global chitosan market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Asia Pacific holds the largest share in the global chitosan market, which is followed by North America and Europe. Japan is dominating the chitosan market in APAC region, followed by China and the South Korea. The chitosan market in Japan is estimated to be the largest. The demand for chitosan in Japan is expected to rise due to growing investment in research and development by manufacturers along with the growing number of applications such as food and beverages, pharmaceuticals, and others. Additionally, robust growth in product offerings is impacting the market growth in this country.
Overall size of the global chitosan market has been derived using primary and secondary source. The research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information related to the global chitosan market. Also, multiple primary interviews were conducted with industry participants and commentators in order to validate data and analysis. The participants who take part in such a process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers, and external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the global chitosan market.
Reasons to Buy:
- Highlights key business priorities to assist companies realign their business strategies.
- Features key findings and crucial progressive industry trends in the global chitosan market, thereby allowing players to develop effective long-term strategies.
- Develops/modifies business expansion plans by using substantial growth offering from developed and emerging markets.
- Scrutinizes in-depth market trends as well as key market drivers and restraints.
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.
- Essential Properties of Chitosan
- Importance of Chitosan in the Human Nutrition Industry
- Side Effects of Chitosan
- Increasing awareness of chitosan
Growing Demand of Chitosan in North America and Europe
- Advanced Biopolymers AS
- KitoSano S.L.
- FMC Corporation
- G.T.C. Bio Corporation
- Golden-Shell Pharmaceutical
- Heppe Medical Chitosan GmbH
- Kitozyme, LLC.
- Panvo Organics Pvt. Ltd
- Primex EHF
- Qingdao Yunzhou Biochemistry Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/iwpnv2